Table 2 |
||||
|
Clinical and management features of different forms of HIES |
||||
|
Mutation |
Inheritance |
Cases reported |
Clinical distinctive characteristics |
Management |
|
|
||||
|
STAT3 |
AD |
300-400 (in U.S.); 0.5-1 per million |
Skeletal and dental abnormalities |
Non-immunologic evaluation and treatment, prophylactic antibiotics +/- antifungals |
|
TYK2 |
AR |
1-2 (none in U.S.) |
No pneumatoceles, recurrent viral infections, mycobacterial infection |
Prophylactic antibiotics +/- antifungals +/- antivirals |
|
DOC8 |
AR |
50-60 |
Recurrent viral infections, food allergies/rhinitis, lymphopenia, increased risk of malignancy, CNS vasculitis |
Prophylactic antibiotics and antivirals +/- antifungals, IVIG if antibody deficiency, allogeneic hematopoietic stem cell transplantation |
|
|
||||
|
Robinson et al. Clinical and Molecular Allergy 2011 9:14 doi:10.1186/1476-7961-9-14 |
||||